✦ LIBER ✦

Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome

✍ Scribed by Druker, Brian J.; Sawyers, Charles L.; Kantarjian, Hagop; Resta, Debra J.; Reese, Sofia Fernandes; Ford, John M.; Capdeville, Renaud; Talpaz, Moshe

Book ID: 120334584
Publisher: Massachusetts Medical Society
Year: 2001
Tongue: English
Weight: 92 KB
Volume: 344
Category: Article
ISSN: 0096-6762
DOI: 10.1056/NEJM200104053441402

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ponatinib: A New Tyrosine Kinase Inhibit

Ponatinib: A New Tyrosine Kinase Inhibitor for the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

✍ Shamroe, C. L.; Comeau, J. M. 📂 Article 📅 2013 🏛 Harvey Whitney Books Company 🌐 English ⚖ 288 KB

Efficacy and Safety of a Specific Inhibi

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

✍ Druker, Brian J.; Talpaz, Moshe; Resta, Debra J.; Peng, Bin; Buchdunger, Elisabe 📂 Article 📅 2001 🏛 Massachusetts Medical Society 🌐 English ⚖ 177 KB

Coexistence of inversion 16 and the Phil

Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis

✍ Soranobu Ninomiya; Nobuhiro Kanemura; Hisashi Tsurumi; Senji Kasahara; Takeshi H 📂 Article 📅 2011 🏛 Carden Jennings Publishing 🌐 English ⚖ 278 KB

Importance of adherence to BCR-ABL tyros

Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia

✍ de Almeida, Maria Helena; Fogliatto, Laura; Couto, Dulce 📂 Article 📅 2014 🏛 SciELO 🌐 English ⚖ 170 KB

Role of Tyrosine Kinase Inhibitors in th

Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

✍ Michael S. Mathisen; Susan O’Brien; Deborah Thomas; Jorge Cortes; Hagop Kantarji 📂 Article 📅 2011 🏛 Current Science Inc. 🌐 English ⚖ 152 KB

Multiple BCR-ABL kinase domain mutations

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

✍ Neil P. Shah; John M. Nicoll; Bhushan Nagar; Mercedes E. Gorre; Ronald L. Paquet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 275 KB